Comparison of the outcomes of laparoscopic pyeloplasty with and without concomitant pyelolithotomy.


Journal

International braz j urol : official journal of the Brazilian Society of Urology
ISSN: 1677-6119
Titre abrégé: Int Braz J Urol
Pays: Brazil
ID NLM: 101158091

Informations de publication

Date de publication:
Historique:
received: 25 12 2018
accepted: 06 05 2019
entrez: 19 10 2019
pubmed: 19 10 2019
medline: 2 11 2019
Statut: ppublish

Résumé

We aimed to evaluate the results of laparoscopic pyeloplasty with concomitant pyelolithotomy and compare results with a cohort of patients undergoing laparoscopic pyeloplasty without pyelolithotomy. We retrospectively reviewed records of 43 patients undergoing transperitoneal laparoscopic Anderson-Hynes dismembered pyeloplasty between December 2012 and July 2018 at our department. Eighteen patients (42%) underwent laparoscopic pyeloplasty with concomitant pyelolithotomy. The results of patients with renal stones were compared with 25 matched patients undergoing laparoscopic pyeloplasty without concomitant renal stones. Demographic data, operative and stone parameters were compared between the groups. The groups were similar regarding to demographic characteristics. All operations were completed laparoscopically with no conversions to open surgery. In 3 cases without renal stones and 15 cases with renal stones, transposition of the ureter due to crossing vessels was performed. The mean stone size was 13±5.24 mm, and the median number of stones was 1 (1-18). The success of laparoscopic pyeloplasty with and without pyelolithotomy was 93.3% and 92.9%, respectively, as confirmed by negative diuretic renogram at postoperative 3rd months. Overall stone-free rate after laparoscopic pyelolithotomy was 93.3%. Mean operative time was 222.6765.71 minutes vs. 219.11±75.63 minutes for the pyeloplasty with concomitant pyelolithotomy vs. pyeloplasty, respectively (p=0.88). Laparoscopic pyeloplasty with concomitant pyelolithotomy is a safe and effective intervention with associated good cosmetic results and high stone-free rates without significant increase in operative time or complications.

Identifiants

pubmed: 31626519
doi: 10.1590/S1677-5538.IBJU.2018.0781
pii: IBJU20180781
pmc: PMC6844342
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

965-973

Informations de copyright

Copyright® by the International Brazilian Journal of Urology.

Déclaration de conflit d'intérêts

None declared.

Références

Urology. 2004 Jul;64(1):16-21; discussion 21
pubmed: 15245924
J Urol. 2008 Oct;180(4):1397-402
pubmed: 18707717
J Endourol. 2008 Jun;22(6):1251-5
pubmed: 18578658
JSLS. 2004 Jul-Sep;8(3):223-8
pubmed: 15347108
J Urol. 1993 Dec;150(6):1795-9
pubmed: 8230507
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Urology. 2008 Apr;71(4):578-80
pubmed: 18387386
Curr Opin Urol. 2011 Mar;21(2):161-5
pubmed: 21178632
Eur Urol. 2007 Oct;52(4):983-9
pubmed: 17629395
Minim Invasive Ther Allied Technol. 2005;14(4):257-61
pubmed: 16754172
J Urol. 2002 Mar;167(3):1378-80
pubmed: 11832737
Urology. 2006 May;67(5):932-6
pubmed: 16635516
J Urol. 1991 Dec;146(6):1492-5
pubmed: 1942325
Urology. 2014 Jan;83(1):243-6
pubmed: 24149107
Res Rep Urol. 2014 May 20;6:43-50
pubmed: 24892032
BJU Int. 2005 Dec;96(9):1365-8
pubmed: 16287459
J Urol. 1993 Dec;150(6):1891-4
pubmed: 8230528
J Urol. 2002 Mar;167(3):1253-6
pubmed: 11832708
J Urol. 1993 Mar;149(3):453-6
pubmed: 8437245
J Endourol. 2009 Sep;23(9):1409-13
pubmed: 19694529
J Urol. 2001 Jun;165(6 Pt 2):2311-5
pubmed: 11371969
J Endourol. 2005 Apr;19(3):353-9
pubmed: 15865527
BJU Int. 2005 Mar;95 Suppl 2:102-5
pubmed: 15720343
J Urol. 1992 Sep;148(3):775-82; discussion 782-3
pubmed: 1512824
J Urol. 2003 May;169(5):1809-12; discussion 1812; author reply 1812
pubmed: 12686849
Cent European J Urol. 2014;66(4):440-4
pubmed: 24757538
Urology. 2004 Feb;63(2):230-4
pubmed: 14972459
J Endourol. 2006 Oct;20(10):707-12
pubmed: 17094743
J Urol. 1996 Aug;156(2 Pt 2):741-3
pubmed: 8683773
Urology. 2017 Nov;109:206-209
pubmed: 28627398
Eur Urol. 2016 Mar;69(3):483-4
pubmed: 26304503
Urol Int. 2008;80(3):306-9
pubmed: 18480637

Auteurs

Mustafa Kadihasanoglu (M)

Department of Urology, Istanbul Training & Research Hospital, Istanbul, Turkey.

Ugur Yucetas (U)

Department of Urology, Istanbul Training & Research Hospital, Istanbul, Turkey.

Emre Karabay (E)

Department of Urology, Istanbul Training & Research Hospital, Istanbul, Turkey.

Erkan Sonmezay (E)

Department of Urology, Istanbul Training & Research Hospital, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH